Rhythm Biosciences Ltd has released a press release.
Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting
- datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development
- Rhythm Initiates Commercialisation of ColoSTAT
- Appendix 4C and Market Update
- Appendix 4E
Later from Rhythm Biosciences
- Rhythm Biosciences Signs Manufacturing Agreement
- ColoSTAT commercial deployment - First physician enrolled
- Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology
- Half-Year Financial Report and Appendix 4D
- Trading Halt
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences